Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
This study has been suspended.
( Study was discontinued because of high drop out rate. )
Study NCT00243984 Information provided by Northeastern Ohio Universities College of Medicine
First Received: October 21, 2005 Last Updated: December 7, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metabolic Syndrome X
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
Diabetes Mellitus
Syndrome
Weight Loss
More general conditions related to this trial
Body Weight
Body Weight Changes
Disease
Endocrine System Diseases
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Metabolic Diseases
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
topiramate
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Central Nervous System Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Northeastern Ohio Universities College of Medicine
Akron General Medical Center
Forum Health
Aultman Health Foundation
St. Elizabeth Health Center
Mercy Medical Center
Back to top of Main Content
